Interpretable machine learning enables early and accurate detection of drug-induced liver injury: A multicenter study with real-world clinical translation
Jingyi Ling , Shian Zhang , Jun Lin , Zhengju Xu , Runcheng Xu , Qian Lv , Kaixiang Zhang , Sheng Liu , Jie Guo , Cheng Hua , Yin Jia , Xiaoyu Xu , Kun Qian , Shanrong Liu
Interdisciplinary Medicine ›› 2026, Vol. 4 ›› Issue (3) : e70091
Drug-induced liver injury (DILI) remains a major clinical challenge due to the absence of specific biomarkers and dependence on subjective diagnostic criteria. This study presents an interpretable gradient-boosting decision tree model (XGB-D) that uses routine laboratory data to enable early and accurate DILI detection. Developed through a multicenter cohort of 36,199 patients, XGB-D shows superior diagnostic performance (area under the curve [AUC] = 0.971) compared with conventional methods and demonstrates robust generalizability across three independent validation cohorts (AUC = 0.881–0.935). SHAP (SHapley Additive exPlanations) analysis identifies alanine aminotransferase and C-reactive protein as key contributors, revealing mechanistic links between hepatocellular damage and inflammatory responses. In prospective real-world monitoring, XGB-D detected DILI signals 2–4 weeks earlier than expert assessment in 29.4% of cases, supporting timely clinical intervention. By integrating interpretable machine learning with clinical hepatology, this work establishes a scalable and transparent framework for precision toxicology with significant implications for drug safety evaluation and personalized medicine.
artificial intelligence / clinical laboratory indicators / diagnosis / drug-induced liver injury
| [1] |
European Association for the Study of the Liver, J. Hepatol. 2019, 70, 1222. |
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
2026 The Author(s). Interdisciplinary Medicine published by Wiley-VCH GmbH on behalf of Nanfang Hospital, Southern Medical University.
/
| 〈 |
|
〉 |